These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23596347)

  • 1. In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation.
    Lim SC; Paech MJ; Sunderland B; Liu Y
    Drug Des Devel Ther; 2013; 7():317-24. PubMed ID: 23596347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I pharmacokinetic and bioavailability study of a sublingual fentanyl wafer in healthy volunteers.
    Lim CB; Schug SA; Sunderland VB; Paech MJ; Liu Y
    Anesth Analg; 2012 Sep; 115(3):554-9. PubMed ID: 22584544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine.
    Lim SCB; Schug S; Krishnarajah J
    Pain Med; 2019 Jan; 20(1):143-152. PubMed ID: 29309700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.
    Lennernäs B; Hedner T; Holmberg M; Bredenberg S; Nyström C; Lennernäs H
    Br J Clin Pharmacol; 2005 Feb; 59(2):249-53. PubMed ID: 15676050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers.
    Rauck R; Oh DA; Parikh N; Koch C; Singla N; Yu J; Nalamachu S; Vetticaden S
    Curr Med Res Opin; 2017 Nov; 33(11):1915-1920. PubMed ID: 28681626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.
    Fisher A; Watling M; Smith A; Knight A
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):138-45. PubMed ID: 20137766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers.
    Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Wilson D; Yu J; Vetticaden S
    Curr Med Res Opin; 2017 Nov; 33(11):1921-1933. PubMed ID: 28942715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study.
    Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Yu J; James S
    Clin Drug Investig; 2018 Aug; 38(8):715-726. PubMed ID: 29909433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs.
    Little AA; Krotscheck U; Boothe DM; Erb HN
    Vet Ther; 2008; 9(3):201-11. PubMed ID: 19003781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
    Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
    Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.
    Rauck RL; Tark M; Reyes E; Hayes TG; Bartkowiak AJ; Hassman D; Nalamachu S; Derrick R; Howell J
    Curr Med Res Opin; 2009 Dec; 25(12):2877-85. PubMed ID: 19814586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual absorption of selected opioid analgesics.
    Weinberg DS; Inturrisi CE; Reidenberg B; Moulin DE; Nip TJ; Wallenstein S; Houde RW; Foley KM
    Clin Pharmacol Ther; 1988 Sep; 44(3):335-42. PubMed ID: 2458208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain.
    Davies A; Mundin G; Vriens J; Webber K; Buchanan A; Waghorn M
    J Pain Symptom Manage; 2016 Mar; 51(3):538-45. PubMed ID: 26706627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
    Vasisht N; Gever LN; Tagarro I; Finn AL
    Clin Drug Investig; 2009; 29(10):647-54. PubMed ID: 19715381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
    Marier JF; Lor M; Potvin D; Dimarco M; Morelli G; Saedder EA
    J Clin Pharmacol; 2006 Jun; 46(6):642-53. PubMed ID: 16707411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a GC-MS assay for the determination of fentanyl pharmacokinetics in rabbit plasma after sublingual spray delivery.
    Malkawi AH; Al-Ghananeem AM; Crooks PA
    AAPS J; 2008 Jun; 10(2):261-7. PubMed ID: 18459057
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.